NASDAQ:LCAV LCA-Vision (LCAV) Stock Price, News & Analysis Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis About LCA-VisionLCA-Vision Inc. is a provider of fixed-site laser vision correction services at its LasikPlus vision centers. The Company's vision centers provide the staff, facilities, equipment and support services for performing laser vision correction that employ advanced laser technologies to help correct nearsightedness, farsightedness and astigmatism. The Company's vision centers are supported by independent, ophthalmologists and credentialed optometrists, as well as other healthcare professionals. The ophthalmologists perform the laser vision correction procedures in the Company's vision centers, and ophthalmologists or optometrists conduct pre-procedure evaluations and post-operative follow-up care in-center. Most of the Company's patients receive a procedure called laser-assisted in situ keratomileusis (LASIK). As of December 31, 2011, it had performed over 1.2 million laser vision correction procedures in its vision centers in the United States and Canada.Read More LCAV Stock News HeadlinesMay 16 at 12:42 AM | msn.comIn A Groundbreaking Study, Researchers Tested A Novel Therapy Using CRISPR Gene Editing In Hopes Of Reversing Childhood Blindness Caused By LCANovember 6, 2023 | investing.comLCAV Historical DataJune 13, 2023 | appleinsider.comApple Vision ProFebruary 21, 2023 | finance.yahoo.comIntradeco Holdings Achieves Life Cycle Assessment (LCA) Certification on Its Manufacturing of Recycled T-Shirts Sold Through Partner Recover BrandsFebruary 7, 2023 | bbc.co.ukLife-cycle assessmentSeptember 3, 2021 | yahoo.comAmazon to block some autocomplete search results for ivermectin, amid misuse for COVID-19September 3, 2021 | yahoo.comCOVID cases remain low after first week of classes at LCCCSee More Headlines Company Calendar Last Earnings4/30/2014Today5/16/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNASDAQ:LCAV CUSIPN/A CIK1003130 Webwww.lasikplus.com Phone+1-513-7929292FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A LCAV Stock Analysis - Frequently Asked Questions How were LCA-Vision's earnings last quarter? LCA-Vision Inc. (NASDAQ:LCAV) posted its quarterly earnings data on Wednesday, April, 30th. The healthcare company reported ($0.01) earnings per share for the quarter, missing analysts' consensus estimates of $0.23 by $0.24. The healthcare company had revenue of $25.53 million for the quarter, compared to analyst estimates of $32.04 million. What other stocks do shareholders of LCA-Vision own? Based on aggregate information from My MarketBeat watchlists, some companies that other LCA-Vision investors own include Amarin (AMRN), Dynatronics (DYNT), Genius Brands International (GNUS), iBio (IBIO), Inovio Pharmaceuticals (INO), Inseego (INSG), Nikola (NKLA), NortonLifeLock (NLOK), Novavax (NVAX) and BurgerFi International (OPES). This page (NASDAQ:LCAV) was last updated on 5/17/2024 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Brokerage Import from Robinhood Robinhood Brokerage Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Never Pay a Monthly Subscription Fee Again. Upgrade your MarketBeat All Access account to a lifetime subscription and lock-in these benefits for life: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Upgrade Your Account Here Questions? Have a Question? — Check out these how-to videos or send us a message: Send Message Please enter a message. Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageCustomize Your NewsletterView Current Brokerage RankingsCheck Out The Live News FeedReview Premium ReportsView The Idea Engine Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.